TY - JOUR
T1 - An integrated national scale SARS-CoV-2 genomic surveillance network
AU - The COVID-19 Genomics UK (COG-UK) Consortium
AU - Smith, Darren
AU - Bashton, Matthew
N1 - Full list of consortium names and affiliations are in the appendix.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.
AB - The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.
U2 - 10.1016/S2666-5247(20)30054-9
DO - 10.1016/S2666-5247(20)30054-9
M3 - Comment/debate
VL - 3
SP - E99-E100
JO - The Lancet Microbe
JF - The Lancet Microbe
SN - 2666-5247
IS - 1
ER -